Clinical Trial Update: CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population

View source ↗

Summary

Clinical trial evaluating methylated SEPT9 (mSEPT9) for colorectal cancer screening in a Chinese population has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenomatous Polyps
• Colorectal Cancer

Snippet

Sponsor: BioChain (Beijing) Science and Technology, Inc. | Conditions: Colorectal Cancer, Adenomatous Polyp of Colon | Status: COMPLETED | Results posted: 2016-01-11